In aggressive cancers, high DMD expression appears to preserve DAPC‐mediated signalling and adhesion, countering metastatic potential, whereas in less aggressive tumours, elevated DMD may drive oncogenic pathways through enhanced cellular remodelling. Here, DMD is linked to cancer.